| Dr Alexandra Stiegler, MD | |
|
6024 Hoover Rd, Grove City, OH 43123-8133 | |
| (614) 627-1880 | |
| Not Available |
| Full Name | Dr Alexandra Stiegler |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 6024 Hoover Rd, Grove City, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164051553 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 35.149125 (Ohio) | Primary |
| Entity Name | Mount Carmel Healthproviders Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356384143 PECOS PAC ID: 9537073804 Enrollment ID: O20031119000634 |
News Archive
How physically active are you? It might depend, in part, on what type of neighborhood you live in, says Adriana Zuniga-Teran, a postdoctoral research associate in the University of Arizona's Udall Center for Studies in Public Policy.
Take extra care at your Memorial Day, Fourth of July and Labor Day celebrations this year by ensuring that accidents do not interfere with summer fun. Dr. Roger Yurt, director of the Hearst Burn Center of NewYork-Presbyterian Hospital/Weill Cornell Medical Center, recommends the following safety tips to avoid burns from barbecues, fireworks and other routine activities that can pose a hazard this season.
The debate over ethical concerns of financial compensation for kidney donation continues to spark controversy, but a discussion in the latest issue of American Journal of Transplantation proposes a practical solution.
ProFibrix B.V., a leader in the development of innovative products for hemostasis and regenerative medicine, today announced the successful closing of a US $11 million series B investment. The financing round was led by new investor Gilde Healthcare Partners, a leading European life sciences investor, who joins existing investor Index Ventures. Dirk Kersten from Gilde will join the company's Supervisory Board.
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today that the European Commission has granted orphan medicinal product designation for RG-012, a single stranded, chemically modified oligonucleotide that binds to and inhibits the function of microRNA-21 ("miR-21") for the treatment of Alport syndrome, a life-threatening genetic kidney disease with no approved therapy.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alexandra Stiegler, MD 6024 Hoover Rd Ste A, Grove City, OH 43123-8133 Ph: () - | Dr Alexandra Stiegler, MD 6024 Hoover Rd, Grove City, OH 43123-8133 Ph: (614) 627-1880 |
News Archive
How physically active are you? It might depend, in part, on what type of neighborhood you live in, says Adriana Zuniga-Teran, a postdoctoral research associate in the University of Arizona's Udall Center for Studies in Public Policy.
Take extra care at your Memorial Day, Fourth of July and Labor Day celebrations this year by ensuring that accidents do not interfere with summer fun. Dr. Roger Yurt, director of the Hearst Burn Center of NewYork-Presbyterian Hospital/Weill Cornell Medical Center, recommends the following safety tips to avoid burns from barbecues, fireworks and other routine activities that can pose a hazard this season.
The debate over ethical concerns of financial compensation for kidney donation continues to spark controversy, but a discussion in the latest issue of American Journal of Transplantation proposes a practical solution.
ProFibrix B.V., a leader in the development of innovative products for hemostasis and regenerative medicine, today announced the successful closing of a US $11 million series B investment. The financing round was led by new investor Gilde Healthcare Partners, a leading European life sciences investor, who joins existing investor Index Ventures. Dirk Kersten from Gilde will join the company's Supervisory Board.
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today that the European Commission has granted orphan medicinal product designation for RG-012, a single stranded, chemically modified oligonucleotide that binds to and inhibits the function of microRNA-21 ("miR-21") for the treatment of Alport syndrome, a life-threatening genetic kidney disease with no approved therapy.
› Verified 2 days ago
Dr. Krisanna L Deppen, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2030 Stringtown Rd, Grove City, OH 43123 Phone: 614-566-0987 Fax: 614-566-0978 | |
Mr. William J Burke, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2030 Stringtown Rd, Grove City, OH 43123 Phone: 614-544-0101 Fax: 614-544-0102 | |
Alece Leeshanna Andrew, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1325 Stringtown Rd Ste 240, Grove City, OH 43123 Phone: 614-788-0130 | |
Evelyn Ann Eakin, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1325 Stringtown Rd Ste 240, Grove City, OH 43123 Phone: 614-788-0130 Fax: 614-788-0538 | |
Michael Evans Joseph, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4191 Kelnor Dr Ste 300, Grove City, OH 43123 Phone: 614-875-6349 | |
Douglas C Wallace, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4072 Gantz Rd, Grove City, OH 43123 Phone: 614-875-0011 Fax: 614-539-7287 | |
Craig William Fortman, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2030 Stringtown Rd Ste 210, Grove City, OH 43123 Phone: 614-544-0050 |